Want to see ENOV full AI Analyst Report?

Enovis (ENOV) Stock Forecast & Price Target

327 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ENOV Analyst Ratings

Strong Buy

11 Buy

1 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Enovis

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ENOV Stock 12 Month Forecast

Average Price Target

$36.55

▲(44.73% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Enovis in the last 3 months. The average price target is $36.55 with a high forecast of $47.00 and a low forecast of $27.00. The average price target represents a 44.73% change from the last price of $25.25.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"17":"$17","48":"$48","24.75":"$24.8","32.5":"$32.5","40.25":"$40.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":47,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$47.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.54545454545455,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$36.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$27.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[17,24.75,32.5,40.25,48],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.05,20.276923076923076,22.503846153846155,24.730769230769234,26.95769230769231,29.184615384615384,31.411538461538463,33.63846153846154,35.86538461538461,38.0923076923077,40.31923076923077,42.54615384615384,44.77307692307693,{"y":47,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.05,19.472727272727273,20.895454545454548,22.31818181818182,23.740909090909092,25.163636363636364,26.586363636363636,28.00909090909091,29.431818181818183,30.854545454545455,32.27727272727273,33.7,35.122727272727275,{"y":36.54545454545455,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,18.05,18.73846153846154,19.426923076923078,20.115384615384617,20.803846153846155,21.492307692307694,22.18076923076923,22.869230769230768,23.557692307692307,24.246153846153845,24.934615384615384,25.623076923076923,26.31153846153846,{"y":27,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":30.46,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.24,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.36,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.64,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.17,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.7,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.37,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.62,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.7,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.04,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.15,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.53,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.05,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$47.00

Average Price Target$36.55

Lowest Price Target$27.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Michael Matson

Needham

$52→$34

Buy

34.65%

Upside

Reiterated

10/12/26

Enovis price target lowered to $34 from $52 at NeedhamEnovis price target lowered to $34 from $52 at Needham

Patrick Wood

UBS

$51→$44

Buy

74.26%

Upside

Reiterated

10/05/26

Analysts Offer Insights on Healthcare Companies: Trulieve Cannabis (NYSE: TRLV) and Enovis (NYSE: ENOV)

Ryan Zimmerman

BTIG

$36

Buy

42.57%

Upside

Reiterated

10/02/26

At the current valuation of ~6.0x NTM EV/EBITDA compared to peers trading closer to ~8.9x, shares remain inexpensive and the risk/reward remains favorable in our view, and we maintain our Buy rating.

Larry Biegelsen

Wells Fargo

$33

Buy

30.69%

Upside

Reiterated

09/08/26

Wells Fargo Remains a Buy on Enovis (ENOV)

David Turkaly

Citizens JMP

$55→$47

Buy

86.14%

Upside

Reiterated

09/02/26

Enovis price target lowered to $47 from $55 at CitizensEnovis price target lowered to $47 from $55 at Citizens

Keith Hinton

Freedom Capital Markets

$41→$36

Buy

42.57%

Upside

Reiterated

09/01/26

We like the deal longer-term and maintain our Buy rating, but we lower our price target to $36 (from $41) based on ~8.0x 2027E EBITDA.

Caitlin Roberts

Canaccord Genuity

$45

Buy

78.22%

Upside

Reiterated

09/01/26

Canaccord Genuity Remains a Buy on Enovis (ENOV)

Vik Chopra

BMO Capital

$30→$27

Buy

6.93%

Upside

Assigned

09/01/26

Enovis price target lowered to $27 from $30 at BMO CapitalEnovis price target lowered to $27 from $30 at BMO Capital

Steven Lichtman

William Blair

―

Buy

―

Reiterated

08/14/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), Enovis (NYSE: ENOV) and Lantheus (NASDAQ: LNTH)

Robbie Marcus

J.P. Morgan

$28

Hold

10.89%

Upside

Reiterated

08/10/26

J.P. Morgan Sticks to Its Hold Rating for Enovis (ENOV)

Vijay Kumar

Evercore ISI

$32

Buy

26.73%

Upside

Reiterated

08/07/26

Evercore ISI Sticks to Their Buy Rating for Enovis (ENOV)

Rong Li

Jefferies

$40

Buy

58.42%

Upside

Reiterated

07/14/26

Enovis (ENOV) Receives a Buy from Jefferies

Jeff Johnson

Robert W. Baird

$45→$37

Buy

46.53%

Upside

Reiterated

05/08/26

Enovis price target lowered to $37 from $45 at BairdEnovis price target lowered to $37 from $45 at Baird

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Michael Matson

Needham

$52→$34

Buy

34.65%

Upside

Reiterated

10/12/26

Enovis price target lowered to $34 from $52 at NeedhamEnovis price target lowered to $34 from $52 at Needham

Patrick Wood

UBS

$51→$44

Buy

74.26%

Upside

Reiterated

10/05/26

Analysts Offer Insights on Healthcare Companies: Trulieve Cannabis (NYSE: TRLV) and Enovis (NYSE: ENOV)

Ryan Zimmerman

BTIG

$36

Buy

42.57%

Upside

Reiterated

10/02/26

At the current valuation of ~6.0x NTM EV/EBITDA compared to peers trading closer to ~8.9x, shares remain inexpensive and the risk/reward remains favorable in our view, and we maintain our Buy rating.

Larry Biegelsen

Wells Fargo

$33

Buy

30.69%

Upside

Reiterated

09/08/26

Wells Fargo Remains a Buy on Enovis (ENOV)

David Turkaly

Citizens JMP

$55→$47

Buy

86.14%

Upside

Reiterated

09/02/26

Enovis price target lowered to $47 from $55 at CitizensEnovis price target lowered to $47 from $55 at Citizens

Keith Hinton

Freedom Capital Markets

$41→$36

Buy

42.57%

Upside

Reiterated

09/01/26

We like the deal longer-term and maintain our Buy rating, but we lower our price target to $36 (from $41) based on ~8.0x 2027E EBITDA.

Caitlin Roberts

Canaccord Genuity

$45

Buy

78.22%

Upside

Reiterated

09/01/26

Canaccord Genuity Remains a Buy on Enovis (ENOV)

Vik Chopra

BMO Capital

$30→$27

Buy

6.93%

Upside

Assigned

09/01/26

Enovis price target lowered to $27 from $30 at BMO CapitalEnovis price target lowered to $27 from $30 at BMO Capital

Steven Lichtman

William Blair

―

Buy

―

Reiterated

08/14/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (NYSE: BMY), Enovis (NYSE: ENOV) and Lantheus (NASDAQ: LNTH)

Robbie Marcus

J.P. Morgan

$28

Hold

10.89%

Upside

Reiterated

08/10/26

J.P. Morgan Sticks to Its Hold Rating for Enovis (ENOV)

Vijay Kumar

Evercore ISI

$32

Buy

26.73%

Upside

Reiterated

08/07/26

Evercore ISI Sticks to Their Buy Rating for Enovis (ENOV)

Rong Li

Jefferies

$40

Buy

58.42%

Upside

Reiterated

07/14/26

Enovis (ENOV) Receives a Buy from Jefferies

Jeff Johnson

Robert W. Baird

$45→$37

Buy

46.53%

Upside

Reiterated

05/08/26

Enovis price target lowered to $37 from $45 at BairdEnovis price target lowered to $37 from $45 at Baird

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ONCBeOne Medicines

OVIDOvid Therapeutics

ASNDAscendis Pharma

QNCXQuince Therapeutics

EHCEncompass Health

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Enovis

3 Months

Jeff JohnsonRobert W. Baird

Success Rate

6/15 ratings generated profit

Average Return

-2.19%

Copying Jeff Johnson's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -2.19% per trade.

1 Year

Vijay KumarEvercore ISI

Success Rate

2/14 ratings generated profit

Average Return

-22.31%

Copying Vijay Kumar's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -22.31% per trade.

2 Years

Vijay KumarEvercore ISI

Success Rate

0/14 ratings generated profit

Average Return

-36.59%

Copying Vijay Kumar's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -36.59% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ENOV Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ENOV has received 19 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ENOV average Analyst price target in the past 3 months is 36.55.

Each month's total comprises the sum of three months' worth of ratings.

ENOV Financial Forecast

ENOV Earnings Forecast

Next quarter’s earnings estimate for ENOV is $0.77 with a range of $0.71 to $0.83. The previous quarter’s EPS was $0.90. ENOV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ENOV has Performed in-line its overall industry.

ENOV Sales Forecast

Next quarter’s sales forecast for ENOV is $557.15M with a range of $552.30M to $563.00M. The previous quarter’s sales results were $582.78M. ENOV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ENOV has Performed in-line its overall industry.

ENOV Stock Forecast FAQ

What is ENOV’s average 12-month price target, according to analysts?

Based on analyst ratings, Enovis’s 12-month average price target is 36.55.

What is ENOV’s upside potential, based on the analysts’ average price target?

Enovis has 44.73% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ENOV a Buy, Sell or Hold?

Enovis has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.

What is Enovis’s price target?

The average price target for Enovis is 36.55. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $47.00 ,the lowest forecast is $27.00. The average price target represents 44.73% Increase from the current price of $25.25.

What do analysts say about Enovis?

Enovis’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of ENOV?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Enovis (ENOV) Stock Forecast & Price Target

ENOV Analyst Ratings

ENOV Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Enovis

ENOV Analyst Recommendation Trends

ENOV Financial Forecast

ENOV Earnings Forecast

ENOV Sales Forecast

ENOV Stock Forecast FAQ

Detailed List of Analyst Forecasts